September / October 2018

ISPE Pharmaceutical Engineering Magazine 2018 September/October Issue Cover

Cover: Meet the Annex 1 Revisions
The first revision to Annex 1 in a decade has rebuilt and reorganized the document to align with GMP in Europe. New sections on scope, utilities, environmental monitoring, and process monitoring; a reorganized and restructured content for a more logical flow; and the introduction of QRM principles make the new and improved Annex 1 critically important for the pharmaceutical industry. Jean-François Dulière, ISPE Comment Team Lead, breaks down the details.

Feature: In-Line, Real-Time Powder Flow and Monitoring
Efficient powder handling and processing is essential for competitive drug manufacture, since most pharmaceuticals, especially oral solid dosage products, are in powder form at some point. While PAT for powder processes has advanced considerably over the last decade, the current analytical solution is suboptimal in some areas, especially related to continuous manufacture. Tim Freeman of Freeman Technology explains.

Special Report: Quality Metrics
A team of writers from the ISPE Quality Metrics Initiative team report on recent developments, including:

  • The proposed ISPE Advancing Pharmaceutical Quality program
  • An MOU between ISPE and PDA to exchange quality metrics and quality culture information
  • The development of a CAPA maturity pilot framework
  • A cross-functional subteam to evaluate and report on the planned FDA quality metrics portal
Subscribe to September / October 2018

Featured Articles

Technical
This article illustrates the importance of experimental conditions to evaluate analytical methods. Italicized text is used throughout the article to emphasize key points and illustrate formula variables.
Features
Innovative technology for in-line real-time powder flow monitoring based on drag force flow measurement offers great potential for efficient monitoring of powder-processing operations.
Technical
The amount of data collected in a typical pharmaceutical manufacturing operation is staggering, yet research shows that much of this information is rarely used for anything more than compliance. New technologies such as big data, artificial intelligence, machine learning, and deep learning permit...
InTouch
Highlights from the stories of the five Category Winners and two Honorable Mentions of this year's Facilities of the Year Awards (FOYA) showcase pharmaceutical industry achievements.
InTouch
This year's ISPE Annual Meeting & Expo will be held from 4 to 7 November in Philadelphia, Pennsylvania. The theme is "Vision to Reality: Delivering Next-Generation Therapies." The first keynote presentation, by Lars Fruergaard Jørgensen, President and CEO, Novo Nordisk A/S and Honorary Conference...
Insights
On 19 June, ISPE officially launched the ISPE Foundation. The philanthropic arm of ISPE "will enhance ISPE's ability to support its members and the pharmaceutical industry as they prepare to address new and evolving industry demands," according to Michael A. Arnold, ISPE Foundation Board Chair, and...
Insights
I write my final "Message from the Chair" article full of a range of thoughts and emotions. Perhaps the best way to sum up my feelings is just to say, "Time flies when you're having fun."